Libor Nechvátal

917 citations
14 papers · 583 · 1 hit paper · h-index 8

Impact in

Papers in

Libor Nechvátal

13 papers receiving 555 citations

Libor Nechvátal's Hit Papers

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial 2025 · 41 citations
410Years since publication10203040

Peers

Libor Nechvátal
Comparison fields: 5 of 35
  • Cardiology and Cardiovascular Medicine 530
  • Family Practice 5
  • Internal Medicine 6
  • Complementary and alternative medicine 18
  • Nephrology 11
Replace Rasa Raugalienė with:
Rasa Raugalienė Lithuania
Mariana Konteva Bulgaria
Sergio Agosti Italy
Maria Lorenza Muiesan Italy
Andrey Baglikov Russia
Haruka Kohno Japan
Norberto Matadamas Hernández Mexico
Francisco Padilla Mexico
Athanasios Kordalis Greece
Egidija Rinkūnienė Lithuania
Libor Nechvátal relative to Rasa Raugalienė Lithuania Rasa Raugalienė's profile →
Citations per field
00.5×1.5×2×2.5×
Rasa Raugalienė · 1×
Citations per year

Countries citing papers authored by Libor Nechvátal

Since Specialization
Citations

This map shows the geographic impact of Libor Nechvátal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libor Nechvátal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libor Nechvátal more than expected).

Fields of papers citing papers by Libor Nechvátal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libor Nechvátal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libor Nechvátal. The network helps show where Libor Nechvátal may publish in the future.

Co-authors

The 12 scholars most cited alongside Libor Nechvátal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Libor Nechvátal Line = papers co-authored together Libor Nechvátal links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 2017249
2 2021127
3 202065
4
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
Hit paper breakdown →
202541
5 202337
6 202224
7 202519
8
Serial echocardiographic assessment of the left ventricular function after direct PCI.
20039
9 20236
10 20032
11
[An axillary metastasis as the first sign of the breast carcinoma--a case review].
20062
12 20081
13 20201
14 20260

About Libor Nechvátal

Libor Nechvátal is a scholar working on Cardiology and Cardiovascular Medicine, Pharmaceutical Science, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Physiology, having authored 14 papers that have together received 583 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (5 papers), Heart Failure Treatment and Management (5 papers), Acute Myocardial Infarction Research (2 papers), Breast Lesions and Carcinomas (1 paper), Advancements in Transdermal Drug Delivery (1 paper), Nitric Oxide and Endothelin Effects (1 paper), Cardiac Imaging and Diagnostics (1 paper) and Cardiac Fibrosis and Remodeling (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (530 citations), Family Practice (5 citations), Internal Medicine (6 citations), Complementary and alternative medicine (18 citations) and Nephrology (11 citations). Libor Nechvátal has collaborated with scholars based in Czechia and United Kingdom. Frequent co-authors include Ladislav Groch, Jan Sitar, Marek Orban, Ota Hlinomaz, František Bednář, Petr Widimský, Jiřı́ Toman, Hana Línková, J Krupicka and P Gregor. Their work appears in journals such as The Lancet, Journal of Thrombosis and Thrombolysis, EClinicalMedicine, Journal of the American College of Cardiology and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact